ITRM930641A0 -
USE OF CARBOXYLIC ACIDS WITH FROM 7 TO 13 CARBON ATOMS OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TOPICAL TREATMENT OF ANTIBIOTIC-RESISTANT OSTEOMYELITIS.
- Google Patents
USE OF CARBOXYLIC ACIDS WITH FROM 7 TO 13 CARBON ATOMS OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TOPICAL TREATMENT OF ANTIBIOTIC-RESISTANT OSTEOMYELITIS.
Info
Publication number
ITRM930641A0
ITRM930641A0ITRM930641AITRM930641AITRM930641A0IT RM930641 A0ITRM930641 A0IT RM930641A0IT RM930641 AITRM930641 AIT RM930641AIT RM930641 AITRM930641 AIT RM930641AIT RM930641 A0ITRM930641 A0IT RM930641A0
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Porro Marcella NazzarofiledCriticalPorro Marcella Nazzaro
Priority to ITRM930641ApriorityCriticalpatent/IT1261938B/en
Publication of ITRM930641A0publicationCriticalpatent/ITRM930641A0/en
Publication of ITRM930641A1publicationCriticalpatent/ITRM930641A1/en
Application grantedgrantedCritical
Publication of IT1261938BpublicationCriticalpatent/IT1261938B/en
ITRM930641A1993-09-241993-09-24Use of carboxylic acids having from 7 to 13 carbon atoms and their physiologically acceptable salts for the production of a drug for the topical treatment of antibiotic-resistant osteomyelitis
IT1261938B
(en)
Use of carboxylic acids having from 7 to 13 carbon atoms and their physiologically acceptable salts for the production of a drug for the topical treatment of antibiotic-resistant osteomyelitis
Use of carboxylic acids having from 7 to 13 carbon atoms and their physiologically acceptable salts for the production of a drug for the topical treatment of antibiotic-resistant osteomyelitis
Use of carboxylic acids having from 7 to 13 carbon atoms and their physiologically acceptable salts for the production of a drug for the topical treatment of antibiotic-resistant osteomyelitis
USE OF 5-METHYLTETRAHYDROFOLIC ACID, 5-FORMYLTETRAHYDROFOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN CONTROLLED-RELEASE FORM ACTIVE IN THE THERAPY OF ORGANIC MENTAL DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS.
New 3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as pharmaceuticals, pharmaceutical products and intermediates
USE OF CARBOXYLIC ACIDS WITH FROM 7 TO 13 CARBON ATOMS OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TOPICAL TREATMENT OF ANTIBIOTIC-RESISTANT OSTEOMYELITIS.
Process for the preparation of acyloxyalkyl esters of therapeutically useful 4-methoxy-10- (1-hydroxyethyl) -11-oxo-1-azatricyclo [7.2.0.03,8] -undec-2-ene-2-carboxylic acids